Injection/Infusion
BUSCOPAN INJ 20MG/ML
Summary
BUSCOPAN INJ 20MG/ML — Injection/Infusion containing hyoscine butylbromide. Hong Kong Registration No. HK-02712. Certificate Holder: ZUELLIG PHARMA LIMITED. Date of Registration: 08 Dec, 1978.
Product NameBUSCOPAN INJ 20MG/ML
Registration No.HK-02712
Certificate HolderZUELLIG PHARMA LIMITED
Holder Address5/F, BERKSHIRE HOUSE TAIKOO PLACE, 25, WESTLANDS ROAD, QUARRY BAY, HONG KONG
Ingredientshyoscine butylbromide
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration08 Dec, 1978
ATC codesA03BB01
ATC Classification
ATC level 1
A Alimentary Tract and Metabolism
All ATC groupsA03
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。